Literature DB >> 25682603

Markedly perturbed hematopoiesis in acid ceramidase deficient mice.

Shaalee Dworski1, Alexandra Berger2, Caren Furlonger2, Joshua M Moreau3, Makoto Yoshimitsu4, Jessa Trentadue2, Bryan C Y Au2, Christopher J Paige5, Jeffrey A Medin6.   

Abstract

Entities:  

Keywords:  Farber disease; acid ceramidase deficient mice; hematopoiesis; histiocytosis; organ architecture

Mesh：

Substances：

Year:  2015        PMID： 25682603      PMCID： PMC4420221          DOI： 10.3324/haematol.2014.108530

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Niemann-Pick disease, type B with TRAP-positive storage cells and secondary sea blue histiocytosis.

Authors:  P Sharma; R Kar; S Dutta; H P Pati; R Saxena
Journal:  Eur J Histochem       Date:  2009-09-23       Impact factor: 3.188

Review 2.  Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease.

Authors:  E Kattner; A Schäfer; K Harzer
Journal:  Eur J Pediatr       Date:  1997-04       Impact factor: 3.183

3.  Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.

Authors:  Michelle M Mielke; Veera Vankata Ratnam Bandaru; Norman J Haughey; Jin Xia; Linda P Fried; Sevil Yasar; Marilyn Albert; Vijay Varma; Greg Harris; Eric B Schneider; Peter V Rabins; Karen Bandeen-Roche; Constantine G Lyketsos; Michelle C Carlson
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

Review 4.  A case of Farber disease.

Authors:  T Fujiwaki; S Hamanaka; M Koga; T Ishihara; R Nishikomori; E Kinoshita; K Furusho
Journal:  Acta Paediatr Jpn       Date:  1992-02

5.  Phenotypic variability in siblings with Farber disease.

Authors:  S E Antonarakis; D Valle; H W Moser; A Moser; S J Qualman; W H Zinkham
Journal:  J Pediatr       Date:  1984-03       Impact factor: 4.406

Review 6.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

Review 7.  A role for sphingolipids in the pathophysiology of obesity-induced inflammation.

Authors:  Benjamin T Bikman
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

Review 8.  The pathogenesis of Niemann-Pick type C disease: a role for autophagy?

Authors:  Chris D Pacheco; Andrew P Lieberman
Journal:  Expert Rev Mol Med       Date:  2008-09-10       Impact factor: 5.600

9.  A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.

Authors:  U Burck; H W Moser; H H Goebel; R Grüttner; K R Held
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

10.  Disseminated lipogranulomatosis.

Authors:  R K Mondal; M Nandi; S Datta; M Hira
Journal:  Indian Pediatr       Date:  2009-02       Impact factor: 1.411
View more
  9 in total

1.  Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.

Authors:  Jakub Sikora; Shaalee Dworski; E Ellen Jones; Mustafa A Kamani; Matthew C Micsenyi; Tomo Sawada; Pauline Le Faouder; Justine Bertrand-Michel; Aude Dupuy; Christopher K Dunn; Ingrid Cong Yang Xuan; Josefina Casas; Gemma Fabrias; David R Hampson; Thierry Levade; Richard R Drake; Jeffrey A Medin; Steven U Walkley
Journal:  Am J Pathol       Date:  2017-04       Impact factor: 4.307

2.  Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment.

Authors:  Mel Pilar Espaillat; Ashley J Snider; Zhijuan Qiu; Breana Channer; Nicolas Coant; Edward H Schuchman; Richard R Kew; Brian S Sheridan; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2017-12-19       Impact factor: 5.191

3.  Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.

Authors:  Fabian P S Yu; Benjamin S Sajdak; Jakub Sikora; Alexander E Salmon; Murtaza S Nagree; Jiří Gurka; Iris S Kassem; Daniel M Lipinski; Joseph Carroll; Jeffrey A Medin
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

4.  Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.

Authors:  Shaalee Dworski; Ping Lu; Aneal Khan; Bruno Maranda; John J Mitchell; Rossella Parini; Maja Di Rocco; Boris Hugle; Makoto Yoshimitsu; Bo Magnusson; Balahan Makay; Nur Arslan; Norberto Guelbert; Karoline Ehlert; Andrea Jarisch; Janet Gardner-Medwin; Rawane Dagher; Maria Teresa Terreri; Charles Marques Lorenco; Lilianna Barillas-Arias; Pranoot Tanpaiboon; Alexander Solyom; James S Norris; Xingxuan He; Edward H Schuchman; Thierry Levade; Jeffrey A Medin
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-01       Impact factor: 5.187

5.  rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.

Authors:  Hanmeng Zhang; Murtaza S Nagree; Haoyuan Liu; Xiaoqing Pan; Jeffrey A Medin; Daniel M Lipinski
Journal:  Gene Ther       Date:  2022-07-28       Impact factor: 4.184

6.  Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.

Authors:  Yedda Li; Yue Xu; Bruno A Benitez; Murtaza S Nagree; Joshua T Dearborn; Xuntian Jiang; Miguel A Guzman; Josh C Woloszynek; Alex Giaramita; Bryan K Yip; Joseph Elsbernd; Michael C Babcock; Melanie Lo; Stephen C Fowler; David F Wozniak; Carole A Vogler; Jeffrey A Medin; Brett E Crawford; Mark S Sands
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-16       Impact factor: 11.205

Review 7.  Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration.

Authors:  Carolina Duarte; Juliet Akkaoui; Chiaki Yamada; Anny Ho; Cungui Mao; Alexandru Movila
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

8.  Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.

Authors:  Fabian P S Yu; Shaalee Dworski; Jeffrey A Medin
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

9.  Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.

Authors:  Nadine Beckmann; Katrin Anne Becker; Stephanie Kadow; Fabian Schumacher; Melanie Kramer; Claudine Kühn; Walter J Schulz-Schaeffer; Michael J Edwards; Burkhard Kleuser; Erich Gulbins; Alexander Carpinteiro
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.